The largest database of trusted experimental protocols

Nexera uhplc

Manufactured by AB Sciex

The Nexera UHPLC is a high-performance liquid chromatography system designed for efficient and reliable analysis. It features advanced technology to provide consistent and accurate separation of complex samples. The Nexera UHPLC is a versatile instrument suitable for a wide range of analytical applications.

Automatically generated - may contain errors

6 protocols using nexera uhplc

1

Quantitative Mass Spectrometry for Protein Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Reduced and alkylated tryptic peptides (5 μL, corresponding to 5 μg extracted protein) were chromatographically separated on a Shimadzu Nexera UHPLC and analyzed on a 6500 QTRAP mass spectrometer (SCIEX) as described previously (Colgrave et al., 2014 (link)). Quantification was achieved using scheduled MRM scanning experiments using a 40 s detection window for each MRM transition and a 0.3 s cycle time. Peaks were integrated using MultiQuant v3.0 (SCIEX) wherein all three transitions were required to co-elute at the same retention time (RT, min) with a signal-to-noise (S/N) > 3 for detection and a S/N > 5 for quantification. Graphs were generated in Graphpad Prism v6.
+ Open protocol
+ Expand
2

Pharmacokinetic Study of Compound 1 and 3

Check if the same lab product or an alternative is used in the 5 most similar protocols
PK studies were performed in male CD-1 mice between 18 and 25 g in weight. The test compound was injected intravenously (i.v.) into CD-1 mice at 0.5 mg/kg in formulation containing 5% DMA (dimethyl acetamide) 15% Solutol HS15 and 80% water. Animals were euthanized at predefined time points by CO2 inhalation and blood was collected in K2-EDTA vacutainers by cardiac puncture. The vials were then centrifuged to collect plasma. The plasma samples were extracted using acetonitrile and then analyzed by LC-MS to determine the concentrations of Compound 1 and Compound 3. LC-MS was performed using a Luna Omega 1.6 μm Polar C18 (Phenomenex) column, a Shimadzu Nexera UHPLC, and a Sciex QTrap 5500 mass spectrometer. The PK parameters were calculated by non-compartmental analysis using Phoenix WinNonlin (Certara).
+ Open protocol
+ Expand
3

Quantitative Proteomics by Targeted LC-MS/MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Reduced and alkylated tryptic peptides (5 μl) were chromatographically separated on a Kinetex C18 column (2.1 mm x 100 mm, Phenomenex) using a linear gradient of 5–45% acetonitrile (in 0.1% formic acid) over 10 min at a flow rate of 400 μl/min. The eluent from the Shimadzu Nexera UHPLC was directed to a QTRAP 6500 mass spectrometer (SCIEX) equipped with a TurboV ionization source operated in positive ion mode for data acquisition and analysis. The MS parameters were as follows: ion spray voltage, 5,500 V; curtain gas, 35; GS1, 35; GS2, 40; source temperature, 500°C; declustering potential, 70 V; and entrance potential, 10 V. Peptides were fragmented in the collision cell with nitrogen gas using rolling collision energy dependent on the size and charge on the size and charge of the precursor ion. Relative quantitation using scheduled multiple reaction monitoring (MRM) scanning experiments (MRM transition peptide information provided in Supplementary Table 3) with a 40 second detection window around the expected retention time (RT) and a 0.3 second cycle time. Data were acquired using Analyst v1.7 software. Peak areas of four MRM transitions were integrated using Skyline (MacLean, Bioinformatics 2010) wherein all transitions were required to co-elute with a signal-to-noise (S/N) > 3 and intensity >1,000 counts per second (cps) for detection.
+ Open protocol
+ Expand
4

Quantitative Peptide Analysis by UHPLC-QTRAP

Check if the same lab product or an alternative is used in the 5 most similar protocols
Reduced and alkylated tryptic peptides (10 μL) were chromatographically separated on a Shimadzu Nexera UHPLC and analyzed on a QTRAP 6500 mass spectrometer (SCIEX), as described previously [30 (link)]. Relative quantitation was done using scheduled MRM scanning experiments with a 40 s detection window around the expected retention time (RT) and a 0.3 s cycle time. Peaks were integrated using MultiQuant v3.0 (SCIEX), wherein all three transitions were required to co-elute with a signal-to-noise (S/N) >5 and intensity >1000 counts per second (cps) for detection. Data were acquired using Analyst v1.5 software (SCIEX), and peak areas of the three MRM transitions were accomplished using MultiQuant v2.0.2 software. Graphs were generated in GraphPad Prism v6 (San Diego, CA, USA).
+ Open protocol
+ Expand
5

In Vitro Hepatic Metabolism Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Compound at 1 μM (0.5% final DMSO concentration) was incubated with a 0.5 mg/mL CD-1 mouse (Sigma), SD rat (Life Technologies), or human liver microsome (Life Technologies) in the presence of 1 mM NADPH at 37°C for up to one hour. Aliquots were taken out at different time points and quenched in acetonitrile containing diclofenac (internal standard). The samples were then centrifuged and the supernatant was analyzed by LC-MS using a Luna Omega 1.6 μm Polar C18 (Phenomenex) column, a Shimadzu Nexera UHPLC, and a Sciex QTrap 5500 mass spectrometer. Verapamil was used as a positive control, and warfarin was used as a negative control.
+ Open protocol
+ Expand
6

Quantitative Bioanalysis of Nicotine

Check if the same lab product or an alternative is used in the 5 most similar protocols
An aliquot of 100 μL
plasma sample was fortified with the internal standard working solution
of nicotine-d4. The sample was then added
to 100 mM ammonium bicarbonate buffer and extracted with ethyl acetate.
The organic phase was evaporated to dryness under a nitrogen stream
and the remaining residue was reconstituted with acetonitrile/methanol
(v/v 75:25). The final extract was analyzed by LC–MS/MS consisting
of a Shimadzu Nexera UHPLC coupled with a Sciex API 5000 MS/MS. Positive
electrospray ionization was applied for data acquisition, and nicotine
was acquired at 163–130 m/z and nicotine-d4 was acquired at 167–134 m/z. The calibration range was 0.200–25.0
ng/mL in the linear regression model with 1/x2 weighting. The method was validated according to requirements
in FDA Bioanalytical Method Validation—Guidance for Industry.20
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!